查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1308671

到 2030 年腸道疾病檢測市場預測 - 按病原體、技術、最終用戶和地區進行的全球分析

Enteric Disease Testing Market Forecasts to 2030 - Global Analysis By Pathogen, Technology (Traditional, Rapid, Convenience Based, Polymerase Chain Reaction, Immunoassay, Chromatography & Spectrometry & Other Technologies), End User & By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 175+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球腸道疾病檢測市場規模將達到 41.8 億美元，預測期內復合年增長率為 8%，到 20.3 億美元將達到 71.6 億美元。

胃腸道感染，包括胃、小腸和大腸，被稱為腸病。 細菌、病毒和寄生蟲等微生物可以引起這些疾病。 艱難梭菌(C. difficile)、彎曲桿菌、霍亂、大腸桿菌、幽門螺桿菌(H. pylori)、沙門氏菌病、痢疾、諾如病毒、輪狀病毒、阿米巴病、隱孢子蟲病、賈第鞭毛蟲病等是腸道疾病的典型例子。

根據世界衛生組織 (WHO) 2020 年 5 月發布的一份報告，食物中毒對於幼兒來說尤其嚴重。 報告稱，腹瀉病是不安全食品引起的最常見疾病，每年影響5.5億人，其中2.2億是五歲以下兒童。

市場動態：

驅動程序：

方便食品的需求增加

忙碌的生活方式正在逐漸將客戶的興趣從傳統的生食轉移到方便包裝的食品，例如冷凍食品和即食食品 (RTE)。 為了提高適銷性，化學品被用來增強食品和飲料的有機特性。 然而，包裝產品中也使用防腐劑來延長保質期。

抑製劑

成本高

由於其廣泛的功能和特性，自動化檢測設備非常昂貴。 例如，基於光譜的系統成本在 150,000 美元到 850,000 美元之間。 估計設備、介質和勞動力成本也可能非常高，具體取決於最終用戶。

機會：

技術進步

整個供應鏈的技術發展和創新改變了業務開展方式。 重點是縮短交貨時間、樣品利用率並降低所提供測試服務的總體成本。 更便宜、更快速、更高效的計算技術與改進的軟件、網絡連接和智能傳感器相結合，在腸道疾病市場中越來越受歡迎。

威脅

缺乏適當的監管

欠發達國家的食品企業仍然高度分散，由小型、無組織的公司主導，這些公司可能沒有執行基本的食品檢測標準，並構成很高的污染風險。 食品和飲料產品檢測，包括包裝食品、乳製品、飲料和肉類產品，需要適當的執行機制、市場參與者之間的協調和配套基礎設施。 然而，新興經濟體的許多國家缺乏這些變量，限制了這些地區食品和水的病原體檢測。

新冠肺炎 (COVID-19) 影響：

在 COVID-19 大流行期間，人們擔心病毒和細菌污染，並選擇自製清潔食品。 因此，感染率有所下降，2020 年和 2021 年進行的檢測數量也有所下降。 在大流行期間，COVID-19 檢測優先於所有其他傳染病檢測。 因此，疫情期間腸道疾病檢測試劑盒的需求減少，阻礙了市場增長。

在預測期內，食品領域預計將是最大的：

在預測期內，隨著食品貿易、公共衛生和政府組織的擴大，需要定期檢查食品質量，並立即採取行動識別、遏制和糾正疫情來源，預計食品行業將佔所佔份額最大。 例如，腸道疾病控制服務局 (FSIS) 制定了基於 HACCP 腸道疾病控制系統的法規，以限制屠宰場和加工廠的肉類和家禽產品污染。

預計快速技術領域在預測期內的複合年增長率最高：

快速技術領域預計在預測期內將出現良好增長。 在食品工業中，用於監測引起食品腐敗、儲存、發酵、安全和食物中毒的微生物的數量、類型和代謝物。 危害分析和關鍵控制點(HACCP) 模型和其他腸道疾病系統的使用已牢牢紮根於質量保證和質量控制(QA/QC) 計劃中，也有助於確保測試“更快、更好、更好”。行業對廉價實時結果的需求也不斷增長。

份額最大的地區：

北美將在 2022 年主導腸道疾病檢測市場，並將在預測期內繼續佔據主導地位。 該地區擁有Abbott Laboratories、Becton Dickinson & Company、Biomerica, Inc、Bio-Rad Laboratories, Inc、Meridian Bioscience, Inc、Quest Diagnostics等幾大公司，以及腸道疾病檢測產品的製造技術也是先進的，正在推動市場的增長。 這主要是由於腸道疾病患者數量的增加、政府對腸道疾病診斷研究的資助增加以及發達國家資本收入的大幅增加。

複合年增長率最高的地區：

該地區大腸桿菌、沙門氏菌病、霍亂、幽門螺桿菌等傳染性腸道疾病患病率不斷增加，中國、印度等人口大國購買力不斷增強，預計太平洋地區在腸道疾病檢測市場的預測期內以最高速度增長。 此外，有吸引力的市場區域位於中國和印度等增長國家，推動亞太地區增長最快。 由於檢測意識的增強和疾病的增加，預計亞太地區將發展最快。

主要進展

2022 年 1 月，Meridian Bioscience Inc. 宣布 Curian Campy 檢測獲得美國食品和藥物管理局 (FDA) 批准。 Curian Campy 檢測是一種快速定性熒光免疫檢測，用於檢測人類糞便樣本中的彎曲桿菌特異性抗原，包括空腸彎曲桿菌、大腸桿菌、烏普薩拉彎曲桿菌和拉裡彎曲桿菌。 該檢測方法專為與 Curian 的免疫熒光測試平台一起使用而開發。

2020 年 1 月，Biomerieux SA 宣布其分子生物學子公司 BioFire Diagnostics 已向美國食品和藥物管理局申請其 BIOFIRE 血培養鑑定 2 (BCID2) 小組的 510(k) 許可。 與現有的 BIOFIRE BCID 組合相比，BIOFIRE BCID2 組合包括幾種額外的病原體、擴大的抗菌素耐藥基因列表和許多修訂的目標。

本報告的內容

  • 區域和國家級市場份額評估
  • 給新進入者的戰略建議
  • 2021 年、2022 年、2023 年、2026 年和 2030 年的綜合市場數據
  • 市場趨勢（促進因素、阻礙因素、機遇、威脅、挑戰、投資機會、建議）
  • 根據市場預測提出關鍵業務領域的戰略建議
  • 競爭格局繪製主要共同趨勢
  • 公司簡介，包括詳細的戰略、財務狀況和最新發展
  • 供應鏈趨勢映射最新技術趨勢

免費定制服務：

訂閱此報告的客戶將獲得以下免費自定義選項之一：

  • 公司簡介
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 主要公司的SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶興趣對主要國家/地區的市場估計/預測/複合年增長率（注：基於可行性檢查）
  • 競爭基準測試
    • 根據產品組合、地域分佈和戰略聯盟對主要參與者進行基準測試

內容

第 1 章執行摘要

第二章前言

  • 概述
  • 利益相關者
  • 調查範圍
  • 調查方法
    • 數據挖掘
    • 數據分析
    • 數據驗證
    • 研究方法
  • 調查來源

第三章市場趨勢分析

  • 驅動程序
  • 制約因素
  • 機會
  • 威脅
  • 技術分析
  • 最終用戶分析
  • 新興市場
  • 新冠肺炎 (COVID-19) 的影響

第 4 章波特五力分析

  • 供應商的議價能力
  • 買家的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間存在敵對關係

第五章全球腸道疾病檢測市場：按病原體分類

  • 彎曲桿菌
  • 梭狀芽胞桿菌
  • 大腸桿菌
  • 腸桿菌科
  • 甲型、乙型、戊型肝炎
  • 單核細胞增生李斯特氏菌
  • 諾如病毒
  • 輪狀病毒
  • 沙門氏菌
  • 金黃色葡萄球菌
  • 弧菌
  • 其他病原體

第六章全球腸道疾病檢測市場：按技術分類

  • 傳統
  • 快
  • 便利基地
  • 聚合□鍊式反應 (PCR)
  • 免疫分析
  • 色譜和光譜分析
  • 其他技術

第 7 章：全球腸道疾病檢測市場：按最終用戶劃分

  • 水
  • 食物
    • 肉類、家禽、海鮮
    • 乳製品
    • 加工食品
    • 水果和蔬菜
    • 堅果、香草和香料
    • 穀物和穀物
    • 其他食物
  • 其他最終用戶

第 8 章：全球腸道疾病檢測市場：按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 意大利
    • 法國
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 新西蘭
    • 韓國
    • 亞太地區其他地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 卡塔爾
    • 南非
    • 其他中東和非洲地區

第 9 章主要進展

  • 合同、夥伴關係、協作和合資企業
  • 收購與合併
  • 推出新產品
  • 業務擴展
  • 其他關鍵策略

第 10 章公司簡介

  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • SGS SA
  • Eurofins Scientific
  • Bureau Veritas
  • Intertek
  • Romer Labs
  • Merieux NutriSciences
  • TUV SUD
  • PerkinElmer, Inc
  • Becton Dickinson
  • Certified Laboratories
  • ALS Limited
  • Neogen Corporation
  • Hardy Diagnostics
Product Code: SMRC23371

According to Stratistics MRC, the Global Enteric Disease Testing Market is accounted for $4.18 billion in 2023 and is expected to reach $7.16 billion by 2030 growing at a CAGR of 8% during the forecast period. Infections of the gastrointestinal tract, including the stomach, small intestine, and large intestine, are known as enteric diseases. Microorganisms such as bacteria, viruses, and parasites can cause these disorders. Clostridium difficile (C. difficile), campylobacteriosis, cholera, Escherichia coli (E. coli), Helicobacter pylori (H. pylori), salmonellosis, shigellosis, norovirus, rotavirus, amebiasis, cryptosporidiosis, and giardiasis are some typical instances of enteric disorders.

According to the World Health Organization (WHO) report published in May 2020, foodborne diseases can be severe, especially for young children. According to the same source, diarrheal diseases are the most common illnesses resulting from unsafe food, with 550 million people falling ill yearly, of which 220 million are children under the age of 5 years.

Market Dynamics:

Driver:

Increase in demand for convenience foods

Busy lives have gradually altered customer focus away from traditional raw food purchases and toward convenience and packaged foods such as frozen foods and ready-to-eat (RTE) meals. To increase marketability, chemicals are employed to enhance the organoleptic properties of food and beverages. However, preservatives are also applied to packaged products to extend their shelf life.

Restraint:

High cost

Automated testing instruments are expensive because they include extensive features and functions. The cost of spectroscopy-based systems, for example, ranges from USD 150,000 to USD 850,000. For some end users, the estimated cost of the instrument, media, and labor is also very high.

Opportunity:

Technological advancements

Technological developments and innovation throughout the supply chain have changed the way business operates. The emphasis is on decreasing lead time, sample utilization, and the overall cost of testing services provided. In the enteric illness market, cheaper, faster, and more efficient computing technology, combined with improved software, network connectivity, and smart sensors, is gaining attraction.

Threat:

Lack of proper regulations

The food business in underdeveloped nations is still extremely fragmented, dominated by small and unorganized firms that may not have implemented basic food testing standards, posing a higher risk of contamination. Food and beverage product testing, such as packaged foods, dairy products, beverages, and meat products, necessitates appropriate enforcement mechanisms, coordination among market parties, and supporting infrastructure. However, many nations in the developing economies cluster lack these variables, limiting pathogen testing in food and water in these locations.

COVID-19 Impact:

People were concerned about viral and bacterial contamination during the COVID-19 pandemic, so they opted for home-cooked or clean cuisine. This resulted in a decreased infection rate and a decrease in the number of tests performed in 2020 and 2021. Also, during the pandemic, COVID-19 testing took precedence over all other infectious disease testing; hence, demand for enteric illness testing kits decreased during the pandemic, hampering market growth.

The food segment is expected to be the largest during the forecast period:

Food segment is expected to hold largest share throughout the projected period with the expansion of the food trade, public health, and government organizations have been driven to regularly check food quality and take immediate action to identify, contain, and correct outbreak origins. For example, the Enteric Disease and Inspection Service (FSIS) has developed regulations based on the HACCP enteric disease control system to limit the contamination of meat and poultry products in slaughterhouses and processing plants.

The rapid technology segment is expected to have the highest CAGR during the forecast period:

Rapid technology segment is expected to have lucrative growth during the forecasted period. It is used in the food industry to monitor the number, type, and metabolites of microorganisms that cause food spoilage, preservation, fermentation, safety, and foodborne pathogens. The use of the Hazard Analysis and Critical Control Points (HACCP) model and other enteric disease systems has become firmly entrenched in quality assurance and quality control (QA/QC) programs, as has the industry's requirement for "faster, better, cheaper" real-time results from tests.

Region with largest share:

North America dominated the enteric disease testing market in 2022 and is likely to continue to do so during the forecast period. The presence of several major players in the region, such as Abbott Laboratories, Becton Dickinson & Company, Biomerica, Inc., Bio-Rad Laboratories, Inc., Meridian Bioscience, Inc., and Quest Diagnostics, as well as advancements in the manufacturing technology of enteric disease testing products, drive the market's growth. This is mostly due to an increase in the number of people suffering from enteric diseases, an increase in government financing for enteric disease diagnosis research, and a considerable increase in capital income in industrialized nations.

Region with highest CAGR:

Due to an increase in the prevalence of infectious enteric diseases such as E. coli, salmonellosis, cholera, and H. pylori in this region, as well as growth in the purchasing power of populated countries such as China and India, Asia-Pacific is expected to grow at the highest pace during the enteric disease testing market forecast period. Additionally, attractive market regions are located in growing countries such as China and India, driving Asia Pacific's most rapid growth. Asia-Pacific is predicted to develop most rapidly, owing to increased testing awareness and rising ailments.

Key players in the market

Some of the key players in Enteric Disease Testing market include Merck KGaA , Thermo Fisher Scientific Inc., SGS SA, Eurofins Scientific, Bureau Veritas, Intertek, Romer Labs, Merieux NutriSciences, TUV SUD, PerkinElmer, Inc, Becton Dickinson, Certified Laboratories, ALS Limited, Neogen Corporation and Hardy Diagnostics.

Key Developments:

In January 2022, Meridian Bioscience Inc. announced that the Curian Campy assay has received U.S. Food and Drug Administration (FDA) clearance. The Curian Campy assay is a rapid, qualitative fluorescent immunoassay for the detection of a Campylobacter-specific antigen including C. jejuni, C. coli, C. upsaliensis, and C. lari in human fecal specimens. The assay was developed to be utilized on the Curian immunofluorescent testing platform.

In January 2020, Biomerieux SA announced that BioFire Diagnostics, its molecular biology affiliate, has submitted to the Food and Drug Administration for 510(k) clearance of the BIOFIRE Blood Culture Identification 2 (BCID2) Panel. The BIOFIRE BCID2 Panel includes several additional pathogens, an expanded list of antimicrobial resistance genes, and many revised targets compared to the existing BIOFIRE BCID Panel.

Pathogens Covered:

  • Campylobacter
  • Clostridium
  • E. coli
  • Enterobacteriaceae
  • Hepatitis A, B, and E
  • Listeria
  • Norovirus
  • Rotavirus
  • Salmonella
  • Shigella
  • Vibrio
  • Other Pathogens

Technologies Covered:

  • Traditional
  • Rapid
  • Convenience Based
  • Polymerase Chain Reaction (PCR)
  • Immunoassay
  • Chromatography & Spectrometry
  • Other Technologies

End Users Covered:

  • Water
  • Food
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Enteric Disease Testing Market, By Pathogen

  • 5.1 Introduction
  • 5.2 Campylobacter
  • 5.3 Clostridium
  • 5.4 E. coli
  • 5.5 Enterobacteriaceae
  • 5.6 Hepatitis A, B, and E
  • 5.7 Listeria
  • 5.8 Norovirus
  • 5.9 Rotavirus
  • 5.10 Salmonella
  • 5.11 Shigella
  • 5.12 Vibrio
  • 5.13 Other Pathogens

6 Global Enteric Disease Testing Market, By Technology

  • 6.1 Introduction
  • 6.2 Traditional
  • 6.3 Rapid
  • 6.4 Convenience Based
  • 6.5 Polymerase Chain Reaction (PCR)
  • 6.6 Immunoassay
  • 6.7 Chromatography & Spectrometry
  • 6.8 Other Technologies

7 Global Enteric Disease Testing Market, By End User

  • 7.1 Introduction
  • 7.2 Water
  • 7.3 Food
    • 7.3.1 Meat, Poultry and Seafood
    • 7.3.2 Dairy Products
    • 7.3.3 Processed Food
    • 7.3.4 Fruits & Vegetables
    • 7.3.5 Nuts, Herbs & Spices
    • 7.3.6 Cereals & Grains
    • 7.3.7 Other Foods
  • 7.4 Other End Users

8 Global Enteric Disease Testing Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Merck KGaA
  • 10.2 Thermo Fisher Scientific Inc.
  • 10.3 SGS SA
  • 10.4 Eurofins Scientific
  • 10.5 Bureau Veritas
  • 10.6 Intertek
  • 10.7 Romer Labs
  • 10.8 Merieux NutriSciences
  • 10.9 TUV SUD
  • 10.10 PerkinElmer, Inc
  • 10.11 Becton Dickinson
  • 10.12 Certified Laboratories
  • 10.13 ALS Limited
  • 10.14 Neogen Corporation
  • 10.15 Hardy Diagnostics

List of Tables

  • Table 1 Global Enteric Disease Testing Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Enteric Disease Testing Market Outlook, By Pathogen (2021-2030) ($MN)
  • Table 3 Global Enteric Disease Testing Market Outlook, By Campylobacter (2021-2030) ($MN)
  • Table 4 Global Enteric Disease Testing Market Outlook, By Clostridium (2021-2030) ($MN)
  • Table 5 Global Enteric Disease Testing Market Outlook, By E. coli (2021-2030) ($MN)
  • Table 6 Global Enteric Disease Testing Market Outlook, By Enterobacteriaceae (2021-2030) ($MN)
  • Table 7 Global Enteric Disease Testing Market Outlook, By Hepatitis A, B, and E (2021-2030) ($MN)
  • Table 8 Global Enteric Disease Testing Market Outlook, By Listeria (2021-2030) ($MN)
  • Table 9 Global Enteric Disease Testing Market Outlook, By Norovirus (2021-2030) ($MN)
  • Table 10 Global Enteric Disease Testing Market Outlook, By Rotavirus (2021-2030) ($MN)
  • Table 11 Global Enteric Disease Testing Market Outlook, By Salmonella (2021-2030) ($MN)
  • Table 12 Global Enteric Disease Testing Market Outlook, By Shigella (2021-2030) ($MN)
  • Table 13 Global Enteric Disease Testing Market Outlook, By Vibrio (2021-2030) ($MN)
  • Table 14 Global Enteric Disease Testing Market Outlook, By Other Pathogens (2021-2030) ($MN)
  • Table 15 Global Enteric Disease Testing Market Outlook, By Technology (2021-2030) ($MN)
  • Table 16 Global Enteric Disease Testing Market Outlook, By Traditional (2021-2030) ($MN)
  • Table 17 Global Enteric Disease Testing Market Outlook, By Rapid (2021-2030) ($MN)
  • Table 18 Global Enteric Disease Testing Market Outlook, By Convenience Based (2021-2030) ($MN)
  • Table 19 Global Enteric Disease Testing Market Outlook, By Polymerase Chain Reaction (PCR) (2021-2030) ($MN)
  • Table 20 Global Enteric Disease Testing Market Outlook, By Immunoassay (2021-2030) ($MN)
  • Table 21 Global Enteric Disease Testing Market Outlook, By Chromatography & Spectrometry (2021-2030) ($MN)
  • Table 22 Global Enteric Disease Testing Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 23 Global Enteric Disease Testing Market Outlook, By End User (2021-2030) ($MN)
  • Table 24 Global Enteric Disease Testing Market Outlook, By Water (2021-2030) ($MN)
  • Table 25 Global Enteric Disease Testing Market Outlook, By Food (2021-2030) ($MN)
  • Table 26 Global Enteric Disease Testing Market Outlook, By Meat, Poultry and Seafood (2021-2030) ($MN)
  • Table 27 Global Enteric Disease Testing Market Outlook, By Dairy Products (2021-2030) ($MN)
  • Table 28 Global Enteric Disease Testing Market Outlook, By Processed Food (2021-2030) ($MN)
  • Table 29 Global Enteric Disease Testing Market Outlook, By Fruits & Vegetables (2021-2030) ($MN)
  • Table 30 Global Enteric Disease Testing Market Outlook, By Nuts, Herbs & Spices (2021-2030) ($MN)
  • Table 31 Global Enteric Disease Testing Market Outlook, By Cereals & Grains (2021-2030) ($MN)
  • Table 32 Global Enteric Disease Testing Market Outlook, By Other Foods (2021-2030) ($MN)
  • Table 33 Global Enteric Disease Testing Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.